← Back to headlines
Merck's Keytruda Shows Survival Benefit in Ovarian Cancer
Merck's cancer drug Keytruda has demonstrated an overall survival benefit in patients with ovarian cancer, according to new findings.
27 Feb, 16:38 — 27 Feb, 16:38
Sources
Showing 1 of 1 sources
